AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Automated Fetal Cardiac Function in Babies Affected by Heart Diseases

Recruitingn/aAges 18 Years - anyFemaleAnna Erenbourg
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this international multicentre prospective observational cohort study with a nested case-control study is to test some automated fetal heart functional parameters in healthy babies compared to those affected by a congenital heart condition. The main questions it aims to answer are: * If there is a significant difference between the two populations of infants * Whether these parameters could significantly improve the predictive value of actual cardiovascular profile score to predict hydrops Participants will be offered two automated cardiac function assessments between 27+6 and 29+6 gestational weeks and between 34+6 and 36+6 weeks of gestation. Functional parameters will be compared between the two study groups and evaluated over time.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Inclusion criteria for the CHD Group are as follows: singleton pregnancies; gestational age between 19+6 and 36+6 weeks gestation, determined by the last menstrual period and confirmed by first trimester ultrasound; isolated congenital cardiac anomaly diagnosed. * Inclusion criteria for the Control Group are as follows: singleton pregnancies; gestational age between 19+6 and 27+6 weeks gestation, determined by the last menstrual period and confirmed by first trimester ultrasound; no congenital cardiac anomaly diagnosed Exclusion Criteria common to the 2 groups (Cases and Controls): * Fetuses whose mothers have comorbidities that have been proven to potentially affect cardiac function including: * intrahepatic cholestasis * pre-gestational and gestational diabetes * preeclampsia * growth restricted fetuses defined as estimated fetal weight or abdominal circumference \<3rd percentile for GA * Fetuses with other structural extracardiac anomalies at ultrasound examination * Fetuses affected by any diagnosed genetic abnormalities
๐Ÿ’Š

What it tests

  • Automated fetal cardiac function evaluation
๐Ÿ“

Where

7 sites
Royal Hospital for Women
Sydney, Australia
Sheba Medical Center
Tel Aviv, Israel
San Salvatore Hospital L'Aquila
Lโ€™Aquila, Italy
Vittore Buzzi Children's Hospital
Milan, Italy
Institute for Maternal and Child Health IRCCS Burlo Garofolo
Trieste, Italy
Centre Hospitalier de Mayotte
Mamoudzou, Mayotte
Medical Center Ujastek
Krakow, Poland
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy